PlainRecalls
FDA Drug Moderate Class II Terminated

Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.

Reported: April 17, 2013 Initiated: February 26, 2013 #D-247-2013

Product Description

Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.

Reason for Recall

Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.

Details

Units Affected
62,187 bottles
Distribution
Nationwide
Location
Sellersville, PA

Frequently Asked Questions

What product was recalled?
Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.. Recalled by Teva Pharmaceuticals USA, Inc.. Units affected: 62,187 bottles.
Why was this product recalled?
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 17, 2013. Severity: Moderate. Recall number: D-247-2013.